Joern Hilfrich
About
In The Last Decade
Joern Hilfrich
11 papers receiving 706 citations
Hit Papers
Peers
Comparison fields: 5 of 68
- Genetics 491
- Oncology 463
- Cancer Research 407
- Pulmonary and Respiratory Medicine 119
- Orthopedics and Sports Medicine 77
Countries citing papers authored by Joern Hilfrich
This map shows the geographic impact of Joern Hilfrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joern Hilfrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joern Hilfrich more than expected).
Fields of papers citing papers by Joern Hilfrich
This network shows the impact of papers produced by Joern Hilfrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joern Hilfrich. The network helps show where Joern Hilfrich may publish in the future.
Co-authorship network of co-authors of Joern Hilfrich
This figure shows the co-authorship network connecting the top 25 collaborators of Joern Hilfrich. A scholar is included among the top collaborators of Joern Hilfrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joern Hilfrich. Joern Hilfrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 10 | |
| 3 | 3 | |
| 4 | 4 | |
| 5 | 4 | |
| 6 | 1 | |
| 7 | 6 | |
| 8 | 1 | |
| 9 | 26 | |
| 10 | Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial breakdown → | 642 |
| 11 | The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer. | 33 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.